- Home
- CXM vs CLDX Comparison
CXM vs CLDX Comparison
Compare CXM & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CXM | CLDX |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | CXM | CLDX |
|---|---|---|
| Price | $6.01 | $23.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $9.89 | ★ $41.56 |
| AVG Volume (30 Days) | ★ 2.1M | 666.2K |
| Earning Date | 03-11-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 180.38 | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $839,147,000.00 | $2,599,000.00 |
| Revenue This Year | $8.25 | N/A |
| Revenue Next Year | $3.44 | $23.23 |
| P/E Ratio | $14.14 | ★ N/A |
| Revenue Growth | ★ 6.48 | N/A |
| 52 Week Low | $5.80 | $14.40 |
| 52 Week High | $9.69 | $30.50 |
Technical Indicators
Market Signals| Indicator | CXM | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 25.09 | 35.84 |
| Support Level | $5.80 | $22.55 |
| Resistance Level | $6.16 | $25.60 |
| Average True Range (ATR) | 0.22 | 1.05 |
| MACD | -0.06 | -0.30 |
| Stochastic Oscillator | 15.70 | 8.05 |
Price Performance
Historical ComparisonAbout CXM Sprinklr Inc.
Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.